Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus

BACKGROUND: Randomized controlled trials showed that newer glucose‐lowering agents are cardioprotective, but most participants were men. It is unknown whether benefits are similar in women. METHODS AND RESULTS: Among adults with type 2 diabetes mellitus not controlled with metformin with no prior us...

Descripción completa

Detalles Bibliográficos
Autores principales: Raparelli, Valeria, Elharram, Malik, Moura, Cristiano S., Abrahamowicz, Michal, Bernatsky, Sasha, Behlouli, Hassan, Pilote, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988160/
https://www.ncbi.nlm.nih.gov/pubmed/31902326
http://dx.doi.org/10.1161/JAHA.119.012940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988160/
https://www.ncbi.nlm.nih.gov/pubmed/31902326
http://dx.doi.org/10.1161/JAHA.119.012940

Ejemplares similares